InterCure Ltd. (INCR)
InterCure Ltd. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Herzliya, TA, IL. The stock last traded at $0.97, up 1.21% on the session, giving a market capitalisation of $57.5M. On trailing twelve-month figures it carries a trailing P/E of -3.97, a net margin of -13.2%. Its beta of 0.57 implies it has historically moved less than the broad market.
InterCure Ltd., including its subsidiaries, is actively involved in the entire lifecycle of medical cannabis products. This encompasses everything from initial research and cultivation to manufacturing, marketing, and global distribution, serving both the Israeli market and international territories. The company's offerings feature dried cannabis flower alongside cannabis extracts infused with oil. Beyond its core cannabis operations, InterCure also directs investments towards the biomedical sector. Founded in 1994, the firm's main offices are located in Herzliya, Israel.
InterCure Ltd. is most often compared with the following Healthcare names: